A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest this time around. We hope to tidy up around the castle, catch up on our napping, hang with our short person, and promenade with the official mascots. And what about you? This is a lovely time of year to enjoy the great outdoors, so perhaps a long drive somewhere is in order. Maybe there is someone special who deserves attention. You could catch up on your reading. Or simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

A Food and Drug Administration advisory panel unanimously recommended the agency approve a new medicine for two rare forms of epilepsy, paving the way for the authorization of what would be the first medication made from marijuana to become available in the U.S., STAT writes. Epidiolex, which is given as an oral solution, consists of cannabidiol, or CBD, a component of cannabis that does not make people high. The manufacturer, GW Pharmaceuticals (GWPH), is seeking its approval to treat Lennox-Gastaut and Dravet syndromes.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.